GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Valeritas Holdings Inc (OTCPK:VLRXQ) » Definitions » Beneish M-Score

Valeritas Holdings (Valeritas Holdings) Beneish M-Score : 0.00 (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Valeritas Holdings Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

The historical rank and industry rank for Valeritas Holdings's Beneish M-Score or its related term are showing as below:

During the past 5 years, the highest Beneish M-Score of Valeritas Holdings was 0.00. The lowest was 0.00. And the median was 0.00.


Valeritas Holdings Beneish M-Score Historical Data

The historical data trend for Valeritas Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeritas Holdings Beneish M-Score Chart

Valeritas Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18
Beneish M-Score
- - -4.64 -3.87 -2.12

Valeritas Holdings Quarterly Data
Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.27 -2.12 -3.04 -2.99 -3.31

Competitive Comparison of Valeritas Holdings's Beneish M-Score

For the Medical Instruments & Supplies subindustry, Valeritas Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Valeritas Holdings's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Valeritas Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Valeritas Holdings's Beneish M-Score falls into.



Valeritas Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Valeritas Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9902+0.528 * 0.9589+0.404 * 0.745+0.892 * 1.1578+0.115 * 1.577
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0851+4.679 * -0.214027-0.327 * 0.6674
=-3.31

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep19) TTM:Last Year (Sep18) TTM:
Total Receivables was $6.42 Mil.
Revenue was 8.463 + 7.514 + 6.403 + 6.894 = $29.27 Mil.
Gross Profit was 4.199 + 3.718 + 3.045 + 3.258 = $14.22 Mil.
Total Current Assets was $39.61 Mil.
Total Assets was $49.23 Mil.
Property, Plant and Equipment(Net PPE) was $9.06 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.23 Mil.
Selling, General, & Admin. Expense(SGA) was $57.31 Mil.
Total Current Liabilities was $19.02 Mil.
Long-Term Debt & Capital Lease Obligation was $19.19 Mil.
Net Income was -13.244 + -14.019 + -14.684 + -11.864 = $-53.81 Mil.
Non Operating Income was -0.05 + -0.006 + 0.053 + -0.005 = $-0.01 Mil.
Cash Flow from Operations was -10.257 + -12.894 + -11.179 + -8.936 = $-43.27 Mil.
Total Receivables was $5.60 Mil.
Revenue was 6.926 + 6.497 + 6.081 + 5.781 = $25.29 Mil.
Gross Profit was 3.177 + 3.092 + 2.897 + 2.612 = $11.78 Mil.
Total Current Assets was $37.96 Mil.
Total Assets was $44.67 Mil.
Property, Plant and Equipment(Net PPE) was $6.03 Mil.
Depreciation, Depletion and Amortization(DDA) was $1.40 Mil.
Selling, General, & Admin. Expense(SGA) was $45.62 Mil.
Total Current Liabilities was $12.68 Mil.
Long-Term Debt & Capital Lease Obligation was $39.27 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(6.42 / 29.274) / (5.6 / 25.285)
=0.219307 / 0.221475
=0.9902

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(11.778 / 25.285) / (14.22 / 29.274)
=0.46581 / 0.485755
=0.9589

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (39.612 + 9.06) / 49.232) / (1 - (37.961 + 6.026) / 44.669)
=0.011375 / 0.015268
=0.745

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=29.274 / 25.285
=1.1578

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(1.401 / (1.401 + 6.026)) / (1.231 / (1.231 + 9.06))
=0.188636 / 0.119619
=1.577

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(57.306 / 29.274) / (45.616 / 25.285)
=1.957573 / 1.804074
=1.0851

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((19.191 + 19.017) / 49.232) / ((39.268 + 12.675) / 44.669)
=0.776081 / 1.162842
=0.6674

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-53.811 - -0.008 - -43.266) / 49.232
=-0.214027

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Valeritas Holdings has a M-score of -3.31 suggests that the company is unlikely to be a manipulator.


Valeritas Holdings Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Valeritas Holdings's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeritas Holdings (Valeritas Holdings) Business Description

Traded in Other Exchanges
N/A
Address
750 Route 202 South, Suite 600, Bridgewater, NJ, USA, 08807
Valeritas Holdings Inc is a commercial-stage medical technology company. It is engaged in the business of improving health and simplifying life for diabetic patients by developing and commercializing innovative technologies. The company designed its first commercialized product, the V-Go Wearable Insulin Delivery Device, or V-Go, that supports the patients with Type 2 diabetes who need insulin to achieve and maintain their target blood glucose goals. V-Go is a small easy-to-use disposable insulin delivery device that a patient wears on his or her skin every 24 hours. It commenced commercial sales of V-Go first in the US and has a sales footprint spread across the country. The company primarily generates its revenues in the United States.
Executives
Armistice Capital, Llc 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Armistice Capital Master Fund Ltd. 10 percent owner C/O ARMISTICE CAPITAL, LLC, 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Steven Boyd 10 percent owner 510 MADISON AVENUE, 7TH FLOOR, NEW YORK NY 10022
Cr Group L.p. 10 percent owner 1000 MAIN STREET, SUITE 2500, HOUSTON TX 77002
Joseph M Mandato director 765 MARKET STREET SUITE 290, SAN FRANCISCO CA 941003
Peter Devlin director 65 WALNUT AVENUE, ANDOVER MA 01810
Brian K Roberts director DIGITAS INC.,, 800 BOYLSTON STREET, BOSTON MA 02199
Erick Lucera officer: See Remarks 138 THISTLE ROAD, NORTH ANDOVER MA 08145
Geoffrey Jenkins officer: See Remarks C/O UV SOLUTIONS, 15 GLENBROOK RD, WELLESLEY HILLS MA 02461

Valeritas Holdings (Valeritas Holdings) Headlines

From GuruFocus

Valeritas Announces Third Quarter 2019 Financial Results

By Marketwired Marketwired 11-13-2019